Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...

Nephrotic Syndrome II : Assessment and Medical Management

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...

Renal Corpuscle

Renal Corpuscle

The glomerulus and Bowman's capsule are two essential components of the nephron, which is the functional unit of the kidney. These microscopic structures play a critical role in the process of blood filtration to produce urine.
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous capillaries...

Acute Pyelonephritis I: Introduction

Acute Pyelonephritis I: Introduction

Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such as Proteus,...

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...

Nephrotic Syndrome III : Nursing Management

Nephrotic Syndrome III : Nursing Management

Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Mold and Human Health: a Reality Check.

Clinical reviews in allergy & immunology·2017

Same author

The clinical relevance of complex regional pain syndrome type I: The Emperor's New Clothes.

Autoimmunity reviews·2016

Same author

The Basis of Structure/Function Claims of Nutraceuticals.

Clinical reviews in allergy & immunology·2016

Same author

Fibromyalgia: A Critical and Comprehensive Review.

Clinical reviews in allergy & immunology·2015

Same author

Lyme disease: a rigorous review of diagnostic criteria and treatment.

Journal of autoimmunity·2014

Same author

Diagnosis and classification of idiopathic pulmonary fibrosis.

Autoimmunity reviews·2014

Search research articles

Related Experiment Video

Updated: May 18, 2026

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Published on: June 8, 2022

Lupus nephritis: a critical review.

Andrea T Borchers¹, Naama Leibushor, Stanley M Naguwa

¹Division of Rheumatology, Allergy and Clinical Immunology, University of California at Davis School of Medicine, Davis, CA 95616, United States.

Autoimmunity Reviews

|September 18, 2012

Summary

Lupus nephritis, a severe lupus manifestation, involves type I interferons and immune complexes. Current treatments include corticosteroids, cyclophosphamide, and mycophenolate mofetil, with ongoing research into biologics for better outcomes.

More Related Videos

Murine Bilateral Renal Lymphadenectomy

Murine Bilateral Renal Lymphadenectomy

Published on: December 30, 2025

Related Experiment Videos

Last Updated: May 18, 2026

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Published on: June 8, 2022

Murine Bilateral Renal Lymphadenectomy

Murine Bilateral Renal Lymphadenectomy

Published on: December 30, 2025

Area of Science:

Nephrology
Rheumatology
Immunology

Background:

Lupus nephritis is a severe manifestation of systemic lupus erythematosus, leading to significant morbidity and mortality.
Understanding its pathogenesis, particularly the role of type I interferons and immune complexes activating toll-like receptors, is crucial for developing targeted therapies.
Current treatments aim to balance effectiveness with reduced toxicity.

Purpose of the Study:

To review the pathogenesis of lupus nephritis, focusing on type I interferons.
To analyze the efficacy and safety of established and emerging treatments for lupus nephritis.
To discuss recent treatment guidelines and the role of biologics.

Main Methods:

Review of clinical trials and research on lupus nephritis pathogenesis.
Analysis of treatment strategies including corticosteroids, cyclophosphamide, and mycophenolate mofetil.
Evaluation of newer biologic agents and recent guideline publications.

Main Results:

Type I interferons play a significant role in lupus nephritis pathogenesis via immune complex activation of toll-like receptors.
Corticosteroids and cyclophosphamide are established treatments, but associated with adverse events.
Mycophenolate mofetil demonstrates comparable effectiveness with potentially reduced toxicity.
Biologics have shown limited success compared to other autoimmune diseases.

Conclusions:

Early diagnosis and treatment are critical for preserving renal function in lupus nephritis.
Treatment strategies are evolving to improve efficacy and minimize toxicity.
Further research into targeted therapies, including biologics, is needed.